Categories
News

2021/2022 funding opens for Master’s-level CPPD modules in genomics

Health Education England’s Genomics Education Programme (GEP) has opened the 2021/2022 funding application process for their Master’s-level CPPD modules and qualifications in genomics.

This is an exciting opportunity for NHS healthcare professionals in England who are interested in developing their knowledge of genomics and how it can be applied to clinical practice and medical research.

Seven partner universities will continue delivering a co-ordinated programme of genomic education after being awarded contracts in 2020. NHS employees in England can now apply for funding to undertake up to four individual CPPD modules that start before 31 March 2022.

There is also funding available for those wishing to extend previously awarded qualifications within the Master’s in Genomic Medicines framework.

You can find out more about the modules and how to apply for funding on the Genomics Education Programme website.

Categories
News

Digital breakthrough set to revolutionise clinical trial management!

A unique collaboration between The Royal Marsden NHS Foundation Trust and Hyland content services provider have produced an affordable and effective solution for paperwork-heavy clinical trial management suitable not just for The Royal Marsden but for any other NHS provider involved in clinical research.

Accelerated by the COVID-19 pandemic, which posed difficulties for researchers who needed to access trial information currently kept in hard copy, it will enable agile working, fit for the 21st century and allow pharmaceutical companies who need to check governance for the trials they sponsor to do so remotely. It will also free up physical space used to store huge volumes of paper copies.

Jane Lawrence, Director of Research Operations at The Royal Marsden NHS Foundation Trust said:

“What is so exciting about what we have produced with Hyland is that it is scalable; any NHS organisation with even small amounts of research can use this and where some pharma solutions would be cost-prohibitive, this is an affordable option whether a hospital runs many large multi-centre trials or participates in small tissue studies. As a specialist provider, The Royal Marsden has a responsibility to innovate and ensure that it can act as a test bed of best practice for the NHS. The Trust has a history of trialling new technology in clinic and we are proud that as a large research institution we can also innovate new technology for research data management that others in the NHS can take forward.”

Lisa Emery, Chief Information Officer at The Royal Marsden, said:

“We were already using Hyland’s OnBase enterprise information platform for patient record management, as are many other NHS and private hospitals and clinics, but until now all trial governance still had to be in hard copy and stored in a records office. Our researchers worked closely with Hyland’s developers to build on what we already had in place with OnBase and produce a paperless solution fit for researchers and pharmaceutical organisations”

Having invested resources into creating the Hyland Clinical Trials Management solution, The Royal Marsden will receive commission on certain onward sales, with the proceeds being re-invested into clinical trial administration and legal costs.

Ed McQuiston, Hyland Executive Vice President and Chief Commercial Officer, said:

“We are thrilled to extend our partnership with The Royal Marsden providing an agile and scalable digital data management solution to help manage clinical trial information access and governance remotely. We know the top priority for healthcare providers is, and always will be, their patients – and our focus remains supporting their mission to improve patient experience with innovative technology. The Hyland Clinical Trials Management solution will help NHS trusts evolve their clinical data management processes to ensure continuity for healthcare research providers.”

Categories
News

Meet a clinical scientist

After completing work experience at Great Ormond Street Hospital (GOSH), Clinda Puvirajasinghe was accepted on to the Scientists Training Programme (STP). Now, Clinda is a clinical scientist in the genetics laboratory, currently working on the 100,000 genomes project.

Clinda Puvirajasinghe

When I was at university, it seemed like only doctors were able to impact a patient’s health. Now, as a clinical scientist, I know that the background, indirect patient care that goes into diagnosis and treatment, shows that our work is also able to have an impact to patient management. 

“I’m a clinical scientist in the genetics lab. I’m split across two teams at the moment. One team is in the 100,000 genomes project. Children who have rare diseases have been recruited into this study, often after a long diagnostic odyssey. Their whole genome is being sequenced – it’s my job to analyse and determine the significance of the variants, take interesting variants to a multi-disciplinary team meeting, and report them, if required.”

When I was at university, it seemed like only doctors were able to impact a patient’s health

Clinda Puvirajasinghe, clinical scientist

Work Experience at GOSH

“I completed my bachelors in Molecular Genetics. I then wanted to do the Scientists Training Programme (STP), to become a clinical scientist. But I needed some work experience, because even though the entry requirement is only graduate entry-level, the quantity and calibre of applicants makes it hard to get into. You’re up against PhD students and people who have lots of lab experience, so I felt like I needed some work experience to help my application stand out.

“I applied for a placement at GOSH to improve my application. Despite not getting the placement I applied for, GOSH were able to give me an alternative role. The role I did get was fantastic. It was to help out with work in the deafness team including receiving samples, carrying out the technical work in the labs, analysing results and writing reports to send back to the clinician. It was a wealth of laboratory experience. Unfortunately, I didn’t get and STP offer that year, but I am convinced that I wouldn’t have got as far as interview stage if I hadn’t done summer work experience at GOSH.”

Progress

“The following year, during my Masters in Human Molecular Genetics, there was an opportunity to do a six-month research project at GOSH with the non-invasive prenatal diagnosis team. This further helped my STP application and thanks to this experience, I received an offer for the STP!”

Back to GOSH

“After the STP course, three years later, I returned to GOSH for a fixed-term role that soon changed into a permanent role. I think that GOSH are really good at staff retention and nurturing people through their career path, me being an example. In terms of developing staff, there are a lot of opportunities!

“Another benefit to GOSH is the multi-disciplinary aspect between healthcare professionals and strong academic connections. We have direct input from clinicians regularly. The rich expertise by the Clinical Genetics clinicians downstairs, complement our work very well, enabling optimal and safe patient care.

“The GOSH reputation also appealed to me. GOSH is well-known for its calibre of professionals. There’s an ongoing theme of bettering yourself – or what we call Continual Professional Development (CPD) – it’s always striving to be the best, to keep learning and take on new challenges. It’s allowed me to become involved in lots of exciting projects here.”

Advice to pass on

“A big part of the work we do is creating reports which get sent to the clinicians and saved within the patient’s notes. If you like being analytical, problem solving, paying attention to detail, with lots of challenges, this job is for you. 

“Starting with work experience or placements is also a good thing – here you gain a lot of experience that you later on rely on once you’re further up the career ladder.”

This profile is kindly reproduced from the Great Ormond Street Hospital NHS Trust